DrugPatentWatch Database Preview
Patent: 8,956,600
Summary for Patent: 8,956,600
| Title: | Ophthalmic drug delivery system containing phospholipid and cholesterol |
| Abstract: | An ophthalmic drug delivery system that contains phospholipid and cholesterol for prolonging drug lifetime in the eyes. |
| Inventor(s): | Shih; Sheue-Fang (Taipei, TW), Chang; Po-Chun (Taipei, TW), Tseng; Yun-Long (Taipei, TW), Guo; Luke S. S. (South San Francisco, CA), Hong; Keelung (South San Francisco, CA) |
| Assignee: | Taiwan Liposome Co. Ltd. (Taipei, TW) TLC Biopharmaceuticals, Inc. (South San Francisco, CA) |
| Application Number: | 12/538,435 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,956,600
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 002 | 2004-02-26 | Start Trial | Taiwan Liposome Co. Ltd. (Taipei, TW) TLC Biopharmaceuticals, Inc. (South San Francisco, CA) | 2039-02-26 | RX | Orphan | search |
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | Start Trial | Taiwan Liposome Co. Ltd. (Taipei, TW) TLC Biopharmaceuticals, Inc. (South San Francisco, CA) | 2039-02-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,956,600
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201201034 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2011019410 | Start Trial |
| United States of America | 2011033468 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
